Form 4 for MPLT MapLight Therapeutics, Inc.
Accepted 2026-02-09 00:00:00 ET · period of report 2026-02-05 · accession 0002021233-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-09 | 2026-02-05 | MPLT | Foff Erin Pennock | Chief Medical Off | A - Grant | $0.00 | +13.4K | 403.8K | +3% | $0 |
| D | 2026-02-09 | 2026-02-05 | MPLT | Foff Erin Pennock | Chief Medical Off | A - Grant | $0.00 | +54.2K | 54.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Stock | 2026-02-05 | A | A | 13,360 | $0.00 | 403,835 | D | — | — | (F1) Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on January 1, 2027, and 1/16th of the RSUs shall vest on each subsequent April 1, July 1, October 1 and January 1 thereafter, subject to the Reporting Person's continued service through each vesting date. (F2) Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2026-02-05 | A | A | 54,240 | $0.00 | 54,240 | D | $15.70 · — to 2036-02-04 | 54,240 Voting Common Stock | (F3) 1/4th of the total shares underlying the option shall vest on February 5, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date. |